Onpattro®
Onpattro® (patisiran) is a prescription medicine for adults that treats the polyneuropathy caused by an illness called hereditary ATTR (hATTR) amyloidosis.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
MANUFACTURER: Alnylam |
CLASS: Therapeutic IV Infusion |
WHAT IT TREATS: Neuropathic heredofamilial amyloidosis |
PRESCRIBED BY: Neurologists |
HOW ADMINISTERED: Infusion |
FREQUENCY: 3 weeks |
Length of infusion: 80 mins |
FOR MORE INFORMATION: |